The impact of the haemoglobin level on the response to radiotherapy

Journal of B.U.ON.

Volumn 7, Issue 1, 2002, Pages 31-34

  Haydaroglu A ^a   Yurut V ^a   Arican, A ^a   Yalman, Deniz ^a   Bulent Aras A ^a   Esassolak, M ^a   Ozkok S ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Cervical cancer; Haemoglobin level; Head and neck cancer; Lung cancer; Radiotherapy

Indexed keywords

HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HEAD AND NECK CANCER; HEMOGLOBIN DETERMINATION; HISTOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PROGNOSIS; RADIATION RESPONSE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CARCINOMA;

EID: 0036248683     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Über desensibilisierung gegen Röentgen und Radiumstrallen
2. The oxygen effect and reoxygenation
3. The impact of blood hemoglobin content on the outcome of the radiotherapy
4. Erythropoietin for patients undergoing radiotherapy: A pilot study
5. Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas
6. Radiotherapy and anemia: The clinical experience
7. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer
8. Hemoglobin levels predict local regional control after postoperative radiotherapy for advanced head and cancer
9. Erythropoietin in radiation oncology - A review
10. High-dose-rate intracavitary irradiation using linear source arrangement for stage II and III squamous cell carcinoma of the uterine cervix
11. Tumor hypoxia and anemia: Impact on the efficacy of radiation therapy
12. FIGO IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy
13. Survival of exclusively irradiated patients with NSCLC. Significance of pretherapeutic hemoglobin level
14. Radiotherapy-associated anemia: The scope of the problem
15. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: Results of double-blind and open-label follow-up studies
16. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Final report of a randomized, open-labeled, phase-II trial